United States Biotechnology & Medical Research

Immunic Inc (IMUX)

Track

Immunic Inc. experienced a series of insider buy transactions in June 2025, with the most recent activity occurring on June 13, 2025. Multiple executives and insiders, including the CEO and Executive Chairman, acquired shares during this period. No insider trading activity has been reported in the last three months.
Ticker: IMUX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Immunic Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 13 Jun 2025
Value US$4,872,956.46 | Price 177.07 | Shares 68,710 (-25.5%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-16 2025-06-13 B Purchase
2.4
Nash Duane

Executive Chairman

Executive Director
68,710 -25.5%
177.07
US$4,872,956 		68,710 -25.5% 177.07 US$4,872,956
2025-06-09 2025-06-05 B Purchase
2.2
Tardio Jason

President and COO

Officer
39,982 +33.6%
18.17
US$3,106,697 		39,982 +33.6% 18.17 US$3,106,697
2025-06-05 2025-06-05 B Purchase
3.7
Neermann Joerg
Non-Executive Director
4,776 +26.7%
42.24
US$1,334,680 		4,776 +26.7% 42.24 US$1,334,680
2025-06-06 2025-06-04 B Purchase
3.2
Vitt Daniel

CEO and Director

Executive Director
15,000 +107.1%
0.77
US$11,550 		15,000 +107.1% 0.77 US$11,550
2025-06-05 2025-06-04 B Purchase
3.7
Neermann Joerg
Non-Executive Director
70,000 +70.0%
0.77
US$53,900 		70,000 +70.0% 0.77 US$53,900
2025-06-04 2025-06-03 B Purchase
3.0
Whaley Glenn

Chief Financial Officer

Officer
45,000 +89.1%
0.71
US$32,076 		45,000 +89.1% 0.71 US$32,076
2025-06-04 2025-06-03 B Purchase
2.8
Rudick Richard Alan
Non-Executive Director
143,075 +163.9%
0.70
US$100,024 		143,075 +163.9% 0.70 US$100,024
2024-11-13 2024-11-12 B Purchase
2.8
Rudick Richard Alan
Non-Executive Director
87,300 +inf%
1.15
US$100,369 		87,300 +inf% 1.15 US$100,369
2024-02-28 2024-02-26 B Purchase
3.2
Vitt Daniel

President and CEO

Executive Director
14,000 +3.7%
1.31
US$18,333 		14,000 +3.7% 1.31 US$18,333
2023-05-16 2023-05-15 PP Planned purchase
3.0
Whaley Glenn

Chief Financial Officer

Officer
5,000 +24.4%
1.75
US$8,750 		5,000 +24.4% 1.75 US$8,750
2022-12-15 2022-12-14 B Purchase
3.7
Neermann Joerg
Non-Executive Director
47,000 +88.7%
1.26
US$59,032 		47,000 +88.7% 1.26 US$59,032
2022-12-15 2022-12-13 B Purchase
3.7
Neermann Joerg
Non-Executive Director
35,000 +194.4%
1.25
US$43,610 		35,000 +194.4% 1.25 US$43,610
2022-11-25 2022-11-23 B Purchase
3.7
Neermann Joerg
Non-Executive Director
18,000 +inf%
1.39
US$25,020 		18,000 +inf% 1.39 US$25,020
2022-11-23 2022-11-22 B Purchase
3.2
Vitt Daniel

President and CEO

Executive Director
8,000 +2.2%
1.35
US$10,799 		8,000 +2.2% 1.35 US$10,799
2022-11-08 2022-11-07 PP Planned purchase
3.0
Whaley Glenn

Chief Financial Officer

Officer
5,000 +32.2%
1.50
US$7,475 		5,000 +32.2% 1.50 US$7,475
2022-06-06 2022-06-03 B Purchase
3.2
Vitt Daniel

President and CEO

Executive Director
5,000 +1.4%
3.10
US$15,500 		5,000 +1.4% 3.10 US$15,500
2022-06-06 2022-06-03 B Purchase
3.0
Whaley Glenn

Chief Financial Officer

Officer
3,500 +38.6%
3.05
US$10,658 		3,500 +38.6% 3.05 US$10,658
2022-05-16 2022-05-12 B Purchase
1.9
Muehler Andreas

Chief Medical Officer

Officer
3,500 +1.2%
5.10
US$17,850 		3,500 +1.2% 5.10 US$17,850
2022-05-13 2022-05-12 B Purchase
3.0
Whaley Glenn

Chief Financial Officer

Officer
3,000 +49.4%
5.08
US$15,240 		3,000 +49.4% 5.08 US$15,240
2022-05-13 2022-05-12 B Purchase
2.4
Nash Duane

Executive Chairman

Executive Director
10,000 +83.1%
5.03
US$50,300 		10,000 +83.1% 5.03 US$50,300
2021-08-11 2021-08-10 B Purchase
2.4
Nash Duane

Executive Chairman

Executive Director
1,000 +7.1%
9.80
US$9,800 		1,000 +7.1% 9.80 US$9,800
2021-03-15 2021-03-02 B Purchase
1.9
Muehler Andreas

Chief Medical Officer

Officer
10,006 +3.5%
15.54
US$155,493 		10,006 +3.5% 15.54 US$155,493
2021-03-03 2021-03-02 B Purchase
3.0
Whaley Glenn

PFO and PAO

Officer
1,000 +100.0%
16.48
US$16,480 		1,000 +100.0% 16.48 US$16,480
2020-08-10 2020-08-10 B Purchase
3.0
Whaley Glenn

PFO and PAO

Officer
1,000 +inf%
18.96
US$18,960 		1,000 +inf% 18.96 US$18,960
2020-07-22 2020-07-21 PlS Planned sale
Groeppel Manfred

Chief Operating Officer

Officer
650 -0.2%
15.62
US$10,155 		650 -0.2% 15.62 US$10,155
2020-07-22 2020-07-21 PlS Planned sale
3.2
Vitt Daniel

Chief Executive Officer

Executive Director
1,300 -0.4%
15.62
US$20,310 		1,300 -0.4% 15.62 US$20,310
2020-07-22 2020-07-20 PlS Planned sale
3.2
Vitt Daniel

Chief Executive Officer

Executive Director
5,000 -1.4%
14.44
US$72,200 		5,000 -1.4% 14.44 US$72,200
2020-07-22 2020-07-20 PlS Planned sale
Groeppel Manfred

Chief Operating Officer

Officer
5,000 -1.8%
14.44
US$72,200 		5,000 -1.8% 14.44 US$72,200
2019-12-04 2019-12-04 PlS Planned sale Nash Duane Non-Executive Director
4,400 -30.5%
6.96
US$30,624 		4,400 -30.5% 6.96 US$30,624
2018-09-25 2018-09-25 S Sale Halperin Errol R. Non-Executive Director
10,000 -100.0%
0.29
US$2,900 		10,000 -100.0% 0.29 US$2,900
2018-09-25 2018-09-25 S Sale Halperin Errol R. Non-Executive Director
89,417 -100.0%
0.29
US$25,940 		89,417 -100.0% 0.29 US$25,940
2018-09-24 2018-09-24 S Sale
2.9
BIENAIME JEAN JACQUES
Non-Executive Director
26,619 -59.0%
0.30
US$8,002 		26,619 -59.0% 0.30 US$8,002
2018-09-21 2018-09-19 S Sale Godshall Douglas Evan Non-Executive Director
69,375 -100.0%
0.35
US$24,191 		69,375 -100.0% 0.35 US$24,191
2018-09-17 2018-09-17 S Sale Satter Muneer A Non-Executive Director Large shareholder
7,044,777 -100.0%
0.29
US$2,054,257 		7,044,777 -100.0% 0.29 US$2,054,257
2018-09-17 2018-09-14 S Sale Satter Muneer A Non-Executive Director Large shareholder
447,500 -6.0%
0.36
US$160,384 		447,500 -6.0% 0.36 US$160,384
2018-09-17 2018-09-13 S Sale
2.9
BIENAIME JEAN JACQUES
Non-Executive Director
20,000 -30.7%
0.47
US$9,400 		20,000 -30.7% 0.47 US$9,400
2018-09-17 2018-09-13 S Sale Satter Muneer A Non-Executive Director Large shareholder
3,890,000 -34.2%
0.50
US$1,930,996 		3,890,000 -34.2% 0.50 US$1,930,996
2018-09-17 2018-09-13 S Sale
2.7
Hasnain Faheem
Non-Executive Director
118,243 -96.3%
0.44
US$51,767 		118,243 -96.3% 0.44 US$51,767
2018-09-17 2018-09-13 S Sale
2.7
Hasnain Faheem
Non-Executive Director
59,200 -32.5%
0.44
US$25,912 		59,200 -32.5% 0.44 US$25,912
2018-09-14 2018-09-12 S Sale
3.2
Cohen Cheryl
Non-Executive Director
3,500 -100.0%
0.55
US$1,925 		3,500 -100.0% 0.55 US$1,925
2017-12-14 2017-12-13 B Purchase Satter Muneer A Large shareholder
50,000 +0.4%
5.57
US$278,570 		50,000 +0.4% 5.57 US$278,570
2017-12-14 2017-12-12 B Purchase Satter Muneer A Large shareholder
50,000 +0.4%
5.40
US$269,765 		50,000 +0.4% 5.40 US$269,765
2017-12-11 2017-12-11 B Purchase Satter Muneer A Large shareholder
50,000 +0.4%
4.96
US$248,225 		50,000 +0.4% 4.96 US$248,225
2017-12-11 2017-12-08 B Purchase Satter Muneer A Large shareholder
50,000 +0.4%
4.92
US$246,185 		50,000 +0.4% 4.92 US$246,185
2017-12-11 2017-12-07 B Purchase Satter Muneer A Large shareholder
50,000 +0.4%
4.77
US$238,730 		50,000 +0.4% 4.77 US$238,730
2017-09-15 2017-09-14 B Purchase
2.7
Hasnain Faheem
59,200 +48.2%
4.19
US$247,870 		59,200 +48.2% 4.19 US$247,870
2017-09-14 2017-09-14 B Purchase Satter Muneer A Large shareholder
30,000 +0.3%
4.25
US$127,539 		30,000 +0.3% 4.25 US$127,539
2017-09-14 2017-09-13 B Purchase
2.9
BIENAIME JEAN JACQUES
10,000 +18.1%
4.00
US$39,969 		10,000 +18.1% 4.00 US$39,969
2017-09-14 2017-09-13 B Purchase Satter Muneer A Large shareholder
50,000 +0.5%
4.13
US$206,465 		50,000 +0.5% 4.13 US$206,465
2017-09-14 2017-09-12 B Purchase Satter Muneer A Large shareholder
50,000 +0.5%
3.74
US$187,225 		50,000 +0.5% 3.74 US$187,225
2017-09-12 2017-09-08 B Purchase Satter Muneer A Large shareholder
50,000 +0.5%
3.53
US$176,615 		50,000 +0.5% 3.53 US$176,615
2017-06-15 2017-06-14 B Purchase DUNN JOHN MICHAEL

General Counsel and Secretary
2,400 +25.3%
3.09
US$7,417 		2,400 +25.3% 3.09 US$7,417
2017-06-15 2017-06-14 B Purchase DUNN JOHN MICHAEL

General Counsel and Secretary
100 +1.1%
3.08
US$308 		100 +1.1% 3.08 US$308
2017-06-15 2017-06-14 B Purchase Winters Terence E.

Co-Chairman and CEO

Executive Director
10,000 +5.4%
3.10
US$30,981 		10,000 +5.4% 3.10 US$30,981
2017-06-14 2017-06-14 B Purchase Satter Muneer A Large shareholder
10,000 +0.1%
3.10
US$31,008 		10,000 +0.1% 3.10 US$31,008
2017-06-15 2017-06-13 B Purchase
2.9
BIENAIME JEAN JACQUES
16,000 +40.9%
3.00
US$48,069 		16,000 +40.9% 3.00 US$48,069
2017-06-14 2017-06-13 B Purchase Satter Muneer A Large shareholder
10,000 +0.1%
3.03
US$30,311 		10,000 +0.1% 3.03 US$30,311
2017-06-12 2017-06-12 B Purchase Satter Muneer A Large shareholder
10,000 +0.1%
3.06
US$30,615 		10,000 +0.1% 3.06 US$30,615
2017-06-13 2017-06-09 B Purchase Ashley Robert A.

Chief Technical Officer, EVP
2,000 +inf%
3.18
US$6,360 		2,000 +inf% 3.18 US$6,360
2017-06-12 2017-06-09 B Purchase Satter Muneer A Large shareholder
10,000 +0.1%
3.17
US$31,733 		10,000 +0.1% 3.17 US$31,733
2017-06-12 2017-06-08 B Purchase Satter Muneer A Large shareholder
10,000 +0.1%
3.10
US$30,958 		10,000 +0.1% 3.10 US$30,958
2017-06-09 2017-06-08 B Purchase Nash Duane

President
3,900 +90.2%
3.12
US$12,182 		3,900 +90.2% 3.12 US$12,182
2017-06-07 2017-06-07 B Purchase Satter Muneer A Large shareholder
10,000 +0.1%
3.21
US$32,074 		10,000 +0.1% 3.21 US$32,074
2017-06-07 2017-06-06 B Purchase Satter Muneer A Large shareholder
10,000 +0.1%
3.19
US$31,940 		10,000 +0.1% 3.19 US$31,940
2017-03-27 2017-03-27 B Purchase Satter Muneer A Large shareholder
3,750,000 +52.6%
4.00
US$15,000,000 		3,750,000 +52.6% 4.00 US$15,000,000
2016-08-15 2016-08-12 B Purchase
2.7
Hasnain Faheem
Non-Executive Director
118,243 +2627.6%
5.92
US$699,999 		118,243 +2627.6% 5.92 US$699,999
2015-10-29 2015-10-28 B Purchase Satter Muneer A Non-Executive Director Large shareholder
400,000 +5.9%
5.50
US$2,200,000 		400,000 +5.9% 5.50 US$2,200,000
2015-10-27 2015-10-26 B Purchase DUNN JOHN MICHAEL

General Counsel and Secretary

Officer
2,000 +27.1%
7.00
US$14,000 		2,000 +27.1% 7.00 US$14,000
2015-10-27 2015-10-26 B Purchase Cohen Cheryl Non-Executive Director
3,500 +inf%
7.17
US$25,090 		3,500 +inf% 7.17 US$25,090
2015-10-27 2015-10-23 B Purchase DUNN JOHN MICHAEL

General Counsel and Secretary

Officer
7,385 +inf%
6.76
US$49,933 		7,385 +inf% 6.76 US$49,933
2015-09-11 2015-09-10 B Purchase BIENAIME JEAN JACQUES Non-Executive Director
6,000 +18.1%
3.05
US$18,293 		6,000 +18.1% 3.05 US$18,293
2015-09-11 2015-09-09 B Purchase
2.9
BIENAIME JEAN JACQUES
Non-Executive Director
2,000 +6.4%
3.16
US$6,320 		2,000 +6.4% 3.16 US$6,320
2015-09-11 2015-09-09 B Purchase
2.9
BIENAIME JEAN JACQUES
Non-Executive Director
2,000 +6.9%
3.10
US$6,200 		2,000 +6.9% 3.10 US$6,200
2015-09-11 2015-09-09 B Purchase
2.9
BIENAIME JEAN JACQUES
Non-Executive Director
4,000 +15.9%
3.07
US$12,280 		4,000 +15.9% 3.07 US$12,280
2014-10-14 2014-10-10 B Purchase Winters Terence E.

Co-Chairman and CEO

Executive Director
680 +0.4%
14.90
US$10,132 		680 +0.4% 14.90 US$10,132
Explore more

More insider trading research around Immunic Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America